Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 368

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 368
---
 executives or employees of the Company and are subject to time-based vesting. These potential shares are excluded
from the computation of basic loss per share as these shares are not considered outstanding until vested. No unvested restricted common
stock awards were issued or outstanding during the years ended December 31, 2024 or 2023.

NOTE 5 – PROPERTY AND EQUIPMENT

Property and equipment, net, consisted of the
following as of December 31, 2024 and 2023:

|                                |     | 2024        
 (Successor) | December 31, |   |     | 2023          
 (Predecessor) | December 31, |   |
|:-------------------------------|:----|:------------|-------------:|:--|:----|:--------------|-------------:|:--|
| Laboratory equipment           |     | $           |    2,507,839 |   |     | $             |    2,507,839 |   |
| Computers                      |     |             |       38,323 |   |     |               |       38,323 |   |
| Furniture                      |     |             |        8,429 |   |     |               |        8,429 |   |
| Total cost                     |     |             |    2,554,591 |   |     |               |    2,554,591 |   |
| Less: accumulated depreciation |     |             |   (2,026,070 | ) |     |               |   (1,587,889 | ) |
| Property and equipment, net    |     | $           |      528,521 |   |     | $             |      966,702 |   |

Depreciation expense for
the period from February 14, 2024 through December 31, 2024 for Successor was $. Predecessor depreciation expense for the period
January 1, 2024 through February 13, 2024 and for the year ended December 31, 2023 was $ and $, respectively.

F-45

NOTE 6 – ACCRUED LIABILITIES

Accrued liabilities consisted of the following as of December 31, 2024
and 2023:

|                                               |     | 2024        
 (Successor) | December 31, |     | 2023          
 (Predecessor) | December 31, |
|:--------------------------------